Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St set for higher open after retail earnings; Moderna soars
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Tech selloff weighs down Wall Street as bond yields climb
- Marvell issues Google warrant tied to custom chip deal
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Francisco Partners to acquire Weave Communications for $650M
Intec Pharma (NTEC) IPO Opens Flat
August 4, 2015 10:03 AM EDTToday's IPO for Intec Pharma (NASDAQ: NTEC) opened for trading at $6.00 per share, after pricing 5,025,000 of its ordinary shares at a price to the public of $6.00 per ordinary share.
Maxim Group LLC and Roth Capital Partners are acting as joint book-running... More
Intec Pharma (NTEC) Prices 5.03M Ordinary Share IPO at $6/Share
August 4, 2015 9:28 AM EDTIntec Pharma Ltd. (the "Company") (Nasdaq: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, announced the pricing of its initial public offering in the United States of 5,025,000 of its ordinary shares at a price to the public of $6.00 per ordinary share, before... More
